Literature DB >> 12653834

Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice.

V Holán1, A Zajícová, M Krulova, V Blahoutová, H Wilczek.   

Abstract

Heroin treatment or abusive drug addiction influences many physiological functions, including the reactions of the immune system. Although suppression of various manifestations of the immune system after heroin (or morphine) administration has been reported, we show here that production of proinflammatory cytokines and nitric oxide (NO) was enhanced and allotransplantation reactions were accelerated significantly in heroin-treated recipients. Mice were treated by a subcutaneous administration of heroin (diacetylmorphine) given in one or repeated daily doses. The ability of spleen cells from treated mice to respond in vitro to alloantigens and to produce IL-2, IL-4, IL-10 and IFN-gamma, and the production of IL-1beta, IL-12 and NO by peritoneal macrophages, were tested. Within 2 h after heroin administration, proliferative responses to alloantigens and the production of IL-1beta, IFN-gamma, IL-12 and NO were enhanced significantly. In contrast, the production of anti-inflammatory cytokines IL-4 and IL-10 was at the same time rather decreased. As a consequence, skin allografts in heroin-treated mice were rejected more promptly than in untreated or vehicle-treated recipients. Similarly, the growth of allogeneic tumours induced by high doses of tumour cells was suppressed significantly in heroin-treated mice. The enhancing effects of heroin on the production of proinflammatory cytokines were antagonized by naltrexone, a specific inhibitor of classic opioid receptors. These results show that heroin treatment augments production of proinflammatory cytokines and accelerates allotransplantation reactions. The observations thus illustrate the complexity of the effects of heroin on the immune system and should be taken into account during medical treatment of opiate addicts and in the use of morphine to decrease pain in various clinical situations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653834      PMCID: PMC1808676          DOI: 10.1046/j.1365-2249.2003.02103.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR; E M SPARROW
Journal:  Proc R Soc Lond B Biol Sci       Date:  1954-12-15

2.  Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility.

Authors:  B M Bayer; M R Gastonguay; M C Hernandez
Journal:  Immunopharmacology       Date:  1992 Mar-Apr

3.  Rapid elevation of plasma interleukin-6 by morphine is dependent on autonomic stimulation of adrenal gland.

Authors:  Richard A Houghtling; Barbara M Bayer
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

4.  Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.

Authors:  N Yamamoto; K Einaga-Naito; M Kuriyama; Y Kawada; R Yoshida
Journal:  Transplantation       Date:  1998-03-27       Impact factor: 4.939

5.  Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release.

Authors:  R Pacifici; M Minetti; P Zuccaro; D Pietraforte
Journal:  Int J Immunopharmacol       Date:  1995-09

6.  Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic-pituitary-adrenal axis.

Authors:  S D House; X Mao; G Wu; D Espinelli; W X Li; S L Chang
Journal:  J Neuroimmunol       Date:  2001-08-30       Impact factor: 3.478

7.  Enhancement of the contact hypersensitivity reaction by acute morphine administration at the elicitation phase.

Authors:  C J Nelson; T How; D T Lysle
Journal:  Clin Immunol       Date:  1999-11       Impact factor: 3.969

8.  Plasma levels of interleukin-6 and interleukin-10 are affected by ketorolac as an adjunct to patient-controlled morphine after abdominal hysterectomy.

Authors:  M H Kim; T S Hahm
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

9.  Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone.

Authors:  D T Lysle; M E Coussons; V J Watts; E H Bennett; L A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

10.  Urocanic acid enhances IL-10 production in activated CD4+ T cells.

Authors:  V Holán; L Kuffová; A Zajícová; M Krulová; M Filipec; P Holler; A Jancárek
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

View more
  12 in total

1.  Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors.

Authors:  Ali G Karaji; David Reiss; Audrey Matifas; Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-22       Impact factor: 4.147

2.  Opioid treatment of experimental pain activates nuclear factor-κB.

Authors:  Peggy Compton; Charles Griffis; Elizabeth Crabb Breen; Matthew Torrington; Ryan Sadakane; Eshetu Tefera; Michael R Irwin
Journal:  J Opioid Manag       Date:  2015 Mar-Apr

3.  Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines.

Authors:  Vanessa Rivera-Amill; Rakesh Kumar; Richard J Noel; Yashira Garcia; Idia V Rodriguez; Melween Martinez; Carlos A Sariol; Edmundo Kraiselburd; Marcus Iszard; Mridul Mukherji; Santosh Kumar; Luis D Giavedoni; Anil Kumar
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

4.  Chronic morphine consumption increase allograft rejection rate in rat through inflammatory reactions.

Authors:  Ali Rafati; Sommaye Hamzehie Taj; Negar Azarpira; Assadollah Zarifkar; Ali Noorafshan; Parvaneh Najafizadeh
Journal:  Iran Biomed J       Date:  2011

5.  The Impact of Morphine on the Characteristics and Function Properties of Human Mesenchymal Stem Cells.

Authors:  Vladimir Holan; Kristina Cechova; Alena Zajicova; Jan Kossl; Barbora Hermankova; Pavla Bohacova; Michaela Hajkova; Magdalena Krulova; Petr Svoboda; Eliska Javorkova
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

6.  Essential role of toll-like receptor 2 in morphine-induced microglia activation in mice.

Authors:  Yi Zhang; Hui Li; Yi Li; Xiuli Sun; Mengyang Zhu; Gregory Hanley; Gene Lesage; Deling Yin
Journal:  Neurosci Lett       Date:  2010-12-02       Impact factor: 3.046

7.  Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients.

Authors:  Habibollah Saadat; Seyed Ali Ziai; Maryam Ghanemnia; Mohammad Hasan Namazi; Morteza Safi; Hosein Vakili; Ali Dabbagh; Omid Gholami
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

8.  Impact of Opium Addiction on Levels of Pro- and Anti-inflammatory Cytokines after Surgery.

Authors:  Mohammad Reza Lashkarizadeh; Mohammad Garshasbi; Mohammad Shabani; Shahriar Dabiri; Hadi Hadavi; Hasan Manafi-Anari
Journal:  Addict Health       Date:  2016

Review 9.  Expression of Opioid Receptors in Cells of the Immune System.

Authors:  Jana Brejchova; Vladimir Holan; Petr Svoboda
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

10.  MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-κB signaling and caused opioid-induced immunosuppression in human monocytes.

Authors:  X Long; Y Li; S Qiu; J Liu; L He; Y Peng
Journal:  Transl Psychiatry       Date:  2016-03-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.